Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation

被引:125
|
作者
Carroll, PA [1 ]
Brazeau, E [1 ]
Lagunoff, M [1 ]
机构
[1] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
关键词
KSHV; HHV-8; endothelial; lymphatic; human herpesvirus; angiogenesis; VEGF receptor3; IL-6; podoplanin; Kaposi's sarcoma;
D O I
10.1016/j.virol.2004.07.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV) is necessary for KS, a highly vascularized tumor predominated by endothelial-derived spindle cells that express markers of lymphatic endothelium. Following KSHV infection of TIME cells, an immortalized human dermal microvascular endothelial cell (DMVEC) line, expression of many genes specific to lymphatic endothelium, including VEGFR3, podoplanin, LYVE-1, and Prox-1, is significantly increased. Increases in VEGFR3 and podoplanin protein are also demonstrated following latent infection. Examination of cytokine secretion showed that KSHV infection significantly induces hIL-6 while strongly inhibiting secretion of IL-8, a gene product that is decreased by differentiation of blood to lymphatic endothelial cells. These studies support the hypotheses that latent KSHV infection of blood endothelial cells drives their differentiation to lymphatic endothelial cells, (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:7 / 18
页数:12
相关论文
共 50 条
  • [31] Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus
    Mansouri, Mandana
    Rose, Patrick P.
    Moses, Ashlee V.
    Frueh, Klaus
    JOURNAL OF VIROLOGY, 2008, 82 (19) : 9615 - 9628
  • [32] Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells
    Punjabi, Almira S.
    Carroll, Patrick A.
    Chen, Lei
    Lagunoff, Michael
    JOURNAL OF VIROLOGY, 2007, 81 (05) : 2449 - 2458
  • [33] Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma
    Guttman-Yassky, E
    Kra-Oz, Z
    Dubnov, J
    Friedman-Birnbaum, R
    Segal, I
    Zaltzman, N
    Roth, T
    Schwartz, F
    Linn, S
    Rozenman, D
    David, M
    Silbermann, M
    Barchana, M
    Bergman, R
    Sarid, R
    ARCHIVES OF DERMATOLOGY, 2005, 141 (11) : 1429 - 1434
  • [34] Propagating Kaposi's sarcoma-associated herpesvirus
    Mocarski, ES
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (03): : 214 - 215
  • [35] Kaposi's sarcoma-associated herpesvirus at 27
    Gaglia, Marta Maria
    TUMOUR VIRUS RESEARCH, 2021, 12
  • [36] Biology of Kaposi's sarcoma-associated herpesvirus
    Bryan, BA
    Dyson, OF
    McCubrey, JA
    Akula, SM
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 : 2882 - 2891
  • [37] Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus
    Dittmer, Dirk P.
    Krown, Susan E.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (05) : 452 - 457
  • [38] Kaposi's sarcoma-associated herpesvirus microRNAs
    Gottwein, Eva
    FRONTIERS IN MICROBIOLOGY, 2012, 3
  • [39] Kaposi's Sarcoma-Associated Herpesvirus Induces Nrf2 during De Novo Infection of Endothelial Cells to Create a Microenvironment Conducive to Infection
    Gjyshi, Olsi
    Bottero, Virginie
    Veettil, Mohanan Valliya
    Dutta, Sujoy
    Singh, Vivek Vikram
    Chikoti, Leela
    Chandran, Bala
    PLOS PATHOGENS, 2014, 10 (10)
  • [40] Prevalence of Kaposi's sarcoma-associated herpesvirus infection in haemophilic patients
    Theodossiades, G
    Arvanitakis, L
    Tsevrenis, V
    Nomikou, E
    Zografidis, A
    Bourboulia, D
    Kontopoulou-Griva, I
    HAEMOPHILIA, 2003, 9 (05) : 657 - 659